Literature DB >> 10574690

Physical and biochemical stability of Optison, an injectable ultrasound contrast agent.

S Podell1, C Burrascano, M Gaal, B Golec, J Maniquis, P Mehlhaff.   

Abstract

Optison(R) is an ultrasound contrast agent, consisting of gas-filled microspheres surrounded by a solid shell of heat-denatured human albumin. Size-distribution measurements of these microspheres are a critical stability indicating factor, because loss of encapsulated gas eliminates ultrasound contrast activity. Composition of the encapsulated gas is also critical, because air-filled microspheres do not persist nearly as long in vivo as microspheres filled with less soluble gases. Optison(R) stability has been tested during exposure to chemical substances expected to dissolve microsphere shells. In addition, size-distribution and gas-composition measurements were used to evaluate the effects of external gas composition, elevated temperature, mixing, needle shear and pressure on product stability. Optison(R) microsphere shells dissolve only when exposed to relatively extreme chemical conditions, such as low pH (<4.0), detergents or chaotropic salts. The shells are highly gas-permeable, and microspheres lose encapsulated gas rapidly and irreversibly when exposed to gas-deficient liquids. Pressure, impact stress, and the application of ultrasound energy all cause liquids to become gas-deficient, and also cause irreversible gas loss. Pressure sensitivity differs dramatically between mixed and unmixed microspheres, further supporting the conclusion that gas diffusion is the major cause of Optison(R) instability. To preserve the efficacy of Optison(R) as an ultrasound contrast agent, it is necessary to devote special attention to minimizing opportunities for gas exchange, mixing and exposure to gas-deficient liquids, so that the size distribution and gas composition of the original product are maintained during handling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574690

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  18 in total

1.  In vitro characterization of liposomes and Optison by acoustic scattering at 3.5 MHz.

Authors:  Constantin-C Coussios; Christy K Holland; Ludwika Jakubowska; Shao-Ling Huang; Robert C MacDonald; Ashwin Nagaraj; David D McPherson
Journal:  Ultrasound Med Biol       Date:  2004-02       Impact factor: 2.998

2.  Determination of postexcitation thresholds for single ultrasound contrast agent microbubbles using double passive cavitation detection.

Authors:  Daniel A King; Michael J Malloy; Alayna C Roberts; Alexander Haak; Christian C Yoder; William D O'Brien
Journal:  J Acoust Soc Am       Date:  2010-06       Impact factor: 1.840

3.  Vascular lesions and s-thrombomodulin concentrations from auricular arteries of rabbits infused with microbubble contrast agent and exposed to pulsed ultrasound.

Authors:  James F Zachary; James P Blue; Rita J Miller; William D O'Brien
Journal:  Ultrasound Med Biol       Date:  2006-11       Impact factor: 2.998

4.  Acoustic techniques for assessing the Optison destruction threshold.

Authors:  Tyrone M Porter; Denise A B Smith; Christy K Holland
Journal:  J Ultrasound Med       Date:  2006-12       Impact factor: 2.153

5.  Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle.

Authors:  Azadeh Kheirolomoom; Paul A Dayton; Aaron F H Lum; Erika Little; Eric E Paoli; Hairong Zheng; Katherine W Ferrara
Journal:  J Control Release       Date:  2006-12-23       Impact factor: 9.776

6.  Ultrasonic contrast agent shell rupture detected by inertial cavitation and rebound signals.

Authors:  Azzdine Y Ammi; Robin O Cleveland; Jonathan Mamou; Grace I Wang; S Lori Bridal; William D O'Brien
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2006-01       Impact factor: 2.725

7.  Contrast-enhanced voiding urosonography: in vitro evaluation of a second-generation ultrasound contrast agent for in vivo optimization.

Authors:  Susan J Back; J Christopher Edgar; Douglas A Canning; Kassa Darge
Journal:  Pediatr Radiol       Date:  2015-05-01

8.  Microbubble Compositions, Properties and Biomedical Applications.

Authors:  Shashank Sirsi; Mark Borden
Journal:  Bubble Sci Eng Technol       Date:  2009-11

Review 9.  Nanotechnology as a Versatile Tool for 19F-MRI Agent's Formulation: A Glimpse into the Use of Perfluorinated and Fluorinated Compounds in Nanoparticles.

Authors:  Joice Maria Joseph; Maria Rosa Gigliobianco; Bita Mahdavi Firouzabadi; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2022-02-09       Impact factor: 6.321

10.  Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.

Authors:  Guankui Wang; Halli Benasutti; Jessica F Jones; Guixin Shi; Michael Benchimol; Sandeep Pingle; Santosh Kesari; Yasan Yeh; Li-En Hsieh; Yu-Tsueng Liu; Anthony Elias; Dmitri Simberg
Journal:  Colloids Surf B Biointerfaces       Date:  2017-10-23       Impact factor: 5.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.